Cell MedX Corp (CMXC)

OTCMKTS: CMXC · Delayed Price · USD
0.106
0.000 (-0.28%)
May 20, 2022 4:00 PM - Market closed
Market Cap6.68M
Revenue (ttm)2,340
Net Income (ttm)-876,108
Shares Out62.92M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume40,991
Open0.107
Previous Close0.107
Day's Range0.106 - 0.113
52-Week Range0.100 - 0.318
Beta0.59
Analystsn/a
Price Targetn/a
Earnings Daten/a

About CMXC

Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre...

IndustryHealth Care Equipment & Supplies
CountryUnited States
Stock ExchangeOTCMKTS
Ticker SymbolCMXC
Full Company Profile

News

Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director

Carson City, Nevada--(Newsfile Corp. - April 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of t...

3 weeks ago - Newsfile Corp

Cell MedX Corp. to Attend the 29th Annual Wellness Show 2022 Held in Vancouver, BC

Carson City, Nevada--(Newsfile Corp. - March 24, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of t...

1 month ago - Newsfile Corp